This is Why Women’s Health Must Be Everyone’s Top Investment Priority
Investing in women’s health is not only a moral obligation-it’s also a vast economic opportunity. Because half the world and most of health care decisions are held by women, women’s health issues are grossly underfinanced. New investors are now realizing that investing in women’s health is good for individuals as well as return.
Key Investment Drivers
Untapped Market & Economic Potential
Women make approximately 80% of the purchasing decisions related to healthcare, but women’s health concerns represent only a tiny fraction-of the order of 2-4%-of healthcare R&D and e-health expenditure. If this discrepancy were addressed, the world economy could be stimulated by up to $1 trillion per annum by 2040.
Simple ROI Measurements
Studies have established that for each dollar spent on women’s health, up to $4-$5 of economic value can be generated in the economy as a whole. In a rough-order-of-magnitude analysis, one could see that if a few hundreds of millions of dollars was spent on research grants on women’s health, several billions of dollars of healthcare savings and economic gains can be realized over a few years’ time.
Innovation & Growth in FemTech
FemTech space-niche to products and services such as fertility tech, menopause management, and women’s reproductive health-is poised to reach $60 billion by 2027. Although venture capital is pouring into the health tech space in increasing numbers, whatever little venture enters the health of a woman is a huge opportunity for first-time pioneering investors.
Under-Served Health Needs
Women also have enormous gaps in their care, especially in cardiovascular disease, autoimmune conditions, osteoporosis, and menopause. Most of these conditions remain underdiagnosed, misdiagnosed, or diagnosed late and inappropriately treated, with accompanying unnecessary pain and waste of money. Employing in these categories can potentially liberate tens of billions of market value.
Why Now? The Momentum Is Building
High-profile investment projects have pledged billions to women’s health’s underinvested space, including preeclampsia and endometriosis, maternal health, and menopause.
Investor interest is increasing, with primary finance and healthcare conferences now dedicating full tracks to women’s health innovation.
Women’s health investment increased on a year-over-year basis even as digital health investment overall retreated, even as there were economic tailwinds.
Strategic Rationale for Investors
Mass and expanding marketplace: Women are the primary decision-makers for health care and an underserved but highly active consumer segment.
Economic value: Women’s health technologies generate quantifiable results, frequently with reduced purchase price and high retention.
FemTech growth is accelerating: Menstrual health, fertility, menopause, and sexual wellness startups are picking up pace-and revenue.
Social betterment is in line with ESG objectives: Investments in women’s health advance gender equality, public health, and long-term social resilience.
Smart Investors Should Look Out For
Women-led care models on digital health platforms.
Clinical innovations in diseases that were previously ignored by conventional medicine.
Women-led startups innovating reproductive, hormonal, and chronic disease care with scalable technology-based solutions.
Impact funds with a gender lens investing in financial and social return opportunities.
Conclusion: Women’s health isn’t simply a health problem-it’s a driver of economic change. It has the potential to fuel innovation, close the most pressing gaps, and provide enormous economic dividends. For all impact investors who also wish to benefit, women’s health can’t be an afterthought-it must be a priority.
Add comment